InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
其他已披露买入
1
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Explore the full record of transactions filed by Qiming U.S. Healthcare Fund II, L.P.. Insider active across 3 companies, notably Elevation Oncology, Inc.. Cumulatively, 3 filings have been published. Split: 1 buy · 0 sell. Total volume traded: €3.7m. History available since 29 June 2021. The latest transaction was disclosed on 27 January 2023 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Qiming U.S. Healthcare Fund II, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报3 总计
2,666,666 股@ US$1.50100.0% 占其流量Voting Common StockSEC:0001209191-23-024058:0
标准退出：2023年4月27日 (T+90)
3,310,228 股0Common StockSEC:0000899243-21-031149:0
1,656,577 股0Common StockSEC:0001209191-21-044606:0
3 条申报中的 3 条
About Qiming U.S. Healthcare Fund II, L.P.
Qiming U.S. Healthcare Fund II, L.P. is a declarant linked to Icosavax, Inc., Elevation Oncology, Inc. and Jasper Therapeutics, Inc. The record shows 5 filings in total, and, across the sampled recent filings, purchases of EUR 3671599, with no sales, between 2021-07-01 and 2023-04-11.
